Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Novartis Pharma

This page shows the latest Novartis Pharma news and features for those working in and with pharma, biotech and healthcare.

Havas Life Medicom and ARK lead at 2021 PM Society Digital Awards

Havas Life Medicom and ARK lead at 2021 PM Society Digital Awards

AstraZeneca (AZ), klarify and Novartis Gene Therapies topped the pharma/healthcare organisation leaderboard at the virtual 2021 PM Society Digital Awards. ... Animation. SMA: Race against time by Havas Life Medicom for Novartis Gene Therapies.

Latest news

More from news
Approximately 6 fully matching, plus 568 partially matching documents found.

Latest Intelligence

  • Sourcing R&D innovation: why pharma companies need to evolve their business models Sourcing R&D innovation: why pharma companies need to evolve their business models

    and. CAR-T therapies. Gilead’s acquisition of Kite Pharma and Bristol-Myers Squibb’s acquisition of Juno Therapeutics, as well as the merger and acquisition agreements between Novartis/Spark and ... Novartis/AveXis, are all recent examples of larger

  • Switzerland: a life sciences hub Switzerland: a life sciences hub

    The Swiss flagship pharma and biotech companies such as Roche, Novartis, Actelion and ACImmune tend to garner a lot of attention, but in their small home country there is a rich ... A strong pharma and biotech history and presence. Among the top five big

  • 20 for 2020 – Five pharma leaders to watch in 2020 20 for 2020 – Five pharma leaders to watch in 2020

    It’s too early to say what style Hahn will bring to the role and its impact on the pharma sector. ... drugmaker Sanofi on 1 September last year from a prior role as head of pharma at Novartis.

  • Can protein degraders unlock ‘undruggable’ drug targets? Can protein degraders unlock ‘undruggable’ drug targets?

    1 trial of its lead candidate ARV-110 in prostate cancer earlier this year, ahead of rival biotechs such as C4 Therapeutics and Kymera Therapeutics as well as big pharma firms ... That’s not dampening enthusiasm for the emerging field, however, and by

  • 20 for 2020 – Five pharma companies to watch 20 for 2020 – Five pharma companies to watch

    As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020. ... BMS will become the fourth largest pharma firm by sales – behind Pfizer, Novartis and Roche – and the addition of new Celgene brands like

More from intelligence
Approximately 1 fully matching, plus 18 partially matching documents found.

Latest appointments

  • New hires at Bristol-Myers Squibb, Acceleron and FerGene New hires at Bristol-Myers Squibb, Acceleron and FerGene

    Acceleron . Acceleron Pharma has poached Jay Backstrom (pictured right) from Celgene, where he worked as chief medical officer. ... He has also served in various executive leadership roles at Novartis Pharma and Novartis Oncology, and he began his

  • New faces at Healthware Group and HRW New faces at Healthware Group and HRW

    She spent time at Novartis representing the interests of pharma, and also worked at start-up brand Headspace.

  • Novartis changes executive committee Novartis changes executive committee

    Welteverden, who was previously head of business services for Syngenta, will join Novartis’ Basel base in Switzerland. ... Klinger initially joined Novartis back in 2011 as general counsel, North America for its biopharmaceutical arm Sandoz.

  • Pfizer’s Elizabeth Barrett joins Novartis as its oncology head Pfizer’s Elizabeth Barrett joins Novartis as its oncology head

    She succeeds Bruno Strigini who retires. Novartis has appointed Elizabeth Barrett to head up its oncology franchise based at the group’s headquarters in Switzerland. ... Her long-time commercial pharma industry experience, marketing skills and

  • Novartis Oncology head Bruno Strigini to retire Novartis Oncology head Bruno Strigini to retire

    The head of Novartis Oncology Bruno Strigini is set to step down and retire from the pharmaceutical industry. ... Novartis CEO Joseph Jimenez said: "I'd like to thank Bruno Strigini for his contributions and achievements.

More from appointments
Approximately 0 fully matching, plus 32 partially matching documents found.

Latest from PMHub

  • EPG Health EPG Health

    Mylan, Novartis, Orphan Europe, Philips, Pfizer, Roche, Sanofi, Takeda, UCB, Uriach, Vifor Pharma. ... See how three pharma companies supported the provision of virtual and on-demand scientific meetings for HCPs during COVID-19.

  • How do you define a biotech company?

    Johnson &Johnson and Pfizer are two of the largest pharma companies in the world by revenue but both have numerous biological therapies. ... This approach is particularly apparent in some of the recent examples of technology pioneered by biotech

  • Marketing strategy in complex environments

    Kulveer Singh and Mark Assenti talk through what this means for pharma strategists and their product lines. ... The last few years have seen influential scientific advances, resulting in subtle shifts in how pharma tackles disease treatment.

  • Frontera Group Frontera Group

    We spoke to patients, academics, Pharma, not-for-profit and industry professionals to find out the value of the patient voice. ... help deliver it How Pharma should evolve its practices to drive patient activation.

  • Experienced Healthcare Marketer Gareth Thurston, joins Cello Health Consulting

    Gareth has over 20 years’ experience in senior roles in a number of pharma companies, most recently at Novartis, where he spent seven years in various roles, including Brand Lead Opthalmology, ... biggest pharma companies.” Gareth will be based at

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
integrated medhealth communication

imc group is a leading, independent global healthcare communication group that enables client’s brands to connect with healthcare professionals, payers...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...

Quick links